China SXT Pharmaceuticals (SXTC) news
Recent news
China stocks fell in regular trading, with YRD down 44.1%, SXTC down 31.7% and MOGU down 19.0%.
On October 12, 2026, Chinese equities experienced a broad decline during regular trading sessions. Among the most notable performers, YRD fell by 44.1%, marking one of the largest single-day drops in the market. SXTC also saw a significant decline, falling 31.7%, while MOGU dropped 19.0%. The…
AInvest Wire · 3d agoSouthern Cross Electrical Engineering - Entire anticipated to generate EBIT of at least A$17 mln per annum
Southern Cross Electrical Engineering Limited (ASX:SXE) is projected to generate an EBIT of at least A$17 million annually, based on its recent financial performance and industry outlook. The company reported FY 2024 earnings with a net income of AU$21.9 million, representing a 9.0% increase…
AInvest Wire · 4d agoUniVest Securities, LLC announces closing of $12 million registered direct offering for its client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)
Univest Securities, LLC announced the closing of a registered direct offering for its client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC), raising approximately $9 million in gross proceeds. The offering involved the sale of 4,500,000 units, each consisting of one Class A ordinary share and one…
AInvest Wire · 6d agoChina SXT Pharmaceuticals - To sell 8 mln class A shares at $1.5 per share
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) has announced plans to sell 8 million Class A ordinary shares at a price of $1.50 per share, according to recent reports. This offering is part of the company’s ongoing efforts to raise capital and strengthen its financial position. The offering will…
AInvest Wire · 7d agoChina SXT Pharmaceuticals Inc. announces $12 million registered direct offering
China SXT Pharmaceuticals Inc. (Nasdaq: SXTC) has announced a registered direct offering to raise $12 million in gross proceeds, according to recent filings and related disclosures. The offering includes the sale of shares and pre-funded warrants to institutional investors. This follows a prior…
AInvest Wire · 7d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.